newsfilter
← Latest News
PR Newswire·

NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company developing treatments for...